The Latest Breaking News from MRK

Merck has underperformed the pharmaceuticals industry over the past year, but analysts are highly optimistic about the stock’s prospects.

Deep-pocketed investors have adopted a bearish approach towards Merck Co (NYSE:MRK), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRK usually suggests something big is…

Merck & Co. is projected to report its third-quarter earnings result at the end of this month, and analysts expect a double-digit profit dip.

The healthcare market shows promise due to heightened demand for quality care, technological advancements, preventive measures, and increased public investment, ensuring resilience in any economic condition. Therefore, investors could now consider top healthcare stocks, such as Eli Lilly (LLY), Merck & Co. (MRK), and Abbott Laboratories (ABT). Keep reading.

As the global population ages, the demand for healthcare services surges, making the sector a promising avenue for long-term growth. Investors looking to capitalize on this trend might consider adding healthcare giants like Eli Lilly and Company (LLY), UnitedHealth Group (UNH), and Merck & Co. (MRK) to their watchlist. Read…

Low-volatility stocks are attractive now because they provide stability and reduce risk during market downturns, delivering steady returns amidst economic uncertainty and fluctuating interest rates. Hence, let's examine the fundamentals of low volatility stocks such as Merck & Co. (MRK), George Weston (WNGRF), and Unum (UNM), which are must-buys for…

The healthcare sector is set for robust growth, driven by surging demand for quality treatments, a growing patient base, breakthroughs in biopharma, and supportive policies. Therefore, investors could consider undervalued pharmaceutical stocks like Merck & Co. (MRK), Pfizer (PFE), and Cigna (CI) with significant upside potential. Read more.

Dividend-paying stocks offer investors a reliable income during volatile markets and can help hedge against inflation, particularly as dividends increase over time. Hence, fundamentally solid dividend stocks Merck & Co. (MRK), Verizon Communications (VZ), and Altria Group (MO) could be ideal buy-and-hold candidates. Read more….

Although Pfizer underperformed the Dow Jones this year, analysts are moderately bullish on the stock’s prospects.